Preview

Biomedical Photonics

Advanced search

Fluorescence diagnosis of pre-invasive cervical pathology

https://doi.org/10.24931/2413-9432-2015-4-1-18-21

Abstract

Results of local fluorescence spectroscopy in 185 women with underlying and pre-invasive disease of cervix and high-risk HPV infection are represented. Fluorescence study was performed 2h after intravenous injection of fotoditazin in a dose of 1 mg/kg (wavelength 636.5 nm). Accumulation of the photosensitizer was estimated by diagnostic parameter (DP) value, calculated as mean value of fluorescence scaled to each type of tissue. For normal tissues DP accounted for 0.6±0.4, showing accumulation of the photosensitizer. According to the study the medication did not also accumulate in retention cysts (DP 0.3±0.1), explaining low efficiency of photodynamic therapy for this pathology. The accumulation of fotoditazin depends significantly on type of pathologic tissue. In patients with inflammation, leukoplakia and CIN I accumulation of the photosensitizer in pathologic foci was negligible: DP accounted for 1.7±0.2, 1.8±0.2 and 2.1±0.3, respectively. In sites of endometriosis and CIN II DP was significantly higher and accounted for 8.3±2.1 and 14.1±4.1, respectively. The greatest accumulation of the photosensitizer was registered in sites of CIN III, squamous cell carcinoma and adenocarcinoma. Though DP value for these pathologies had almost no difference and accounted for 23.1±4.7, 22.7±1.8 and 23.3±1.4, respectively. For fluorescence diagnosis of severe dysplasia in 48% of patients borders of fluorescence regions were beyond lesions detected for extended colposcopy with additional areas of fluorescence. Targeted biopsy of these regions proved pathology in all patients: CIN II, CIN III, mild dysplasia or CIS. Thus, local spectroscopy allows to diagnosis multifocal lesions on cervix, to define correctly borders of lesion and consider excisional biopsy in-time.

 

 

About the Author

I. P. Aminodova
Ivanovskiy regional oncological dispensary, Ivanovo LLC «Klinika sovremennoy meditsiny», Ivanovo
Russian Federation


References

1. International Agency for Research on Cancer (IARC) and World Health Organization. Cervical cancer screening, IARC Handbooks of cancer prevention, Vol. 10, Lyon: IARC Press, 2005.

2. Ullrich A., Garwood P., Clayes P. WHO’s Action Plan Against Cervical Cancer, Entre Nous, 2007, No. 64, pp. 4–6.

3. Zlokachestvennye novoobrazovanija v Rossii v 2013 godu (zabolevaemost' i smertnost') (Malignant neoplasms in Russia in 2003 (incidence and mortality)), Pod red. Kaprina A.D., Starinskogo V.V., Petrovoj G.V., M.: MNIOI im. P.A. Gercena, filial FGBU «FMIC im. P.A Gercena» Minzdrava Rossii, 2015, pp. 1–250.

4. Sostojanie onkologicheskoj pomoshhi naseleniju Rossii v 2011 godu (Status of cancer care for Russian population in 2011), Pod redakciej Chissova V.I., Starinskogo V.V., Petrovoj G.V., M.: FGBU «MNIOI im. P.A. Gercena» Minzdravsocrazvitija Rossii, 2012, pp. 1–240.

5. Sopko N.I., Maksimov V.V. Sovremennye predstavlenija o papillomavirusnoj infekcii (Contemporary conceptions of papillomavirus infection), Medicinskie aspekty zhenskogo zdorov'ja, 2006, No. 3, pp. 23–25.

6. Trushina O.I., Novikova E.G. Rol' papillomavirusnoj infekcii v geneze RShM (Role of papillomavirus infection in cervical cancer origin), Rossijskij onkologicheskij zhurnal, 2005, №1, pp. 45–52.

7. Levin M. Skrytye infekcii: bud'te bditel'ny (Occult infections: stay alert), SPb.: Nevskij prospekt, 2000, pp. 1–160.

8. Zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application, Nat. Rev. Cancer, 2002, Vol. 2, pp. 342–350.


Review

For citations:


Aminodova I.P. Fluorescence diagnosis of pre-invasive cervical pathology. Photodynamic therapy and photodyagnosis. 2015;4(1):18-21. (In Russ.) https://doi.org/10.24931/2413-9432-2015-4-1-18-21

Views: 1387


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2413-9432 (Print)